Skip to main content

Table 3 Relationship between the VAT/SMT ratio and severity outcomes

From: Impact of visceral adiposity on severity of acute pancreatitis: a propensity score-matched analysis

VAT/SMT ratio

< 0.6

0.6–0.9

0.9–1.2

1.2–1.5

> 1.5

p value

Number of patients

7

147

60

56

36

 

ICU transfer

0 (0%)

5 (3.4%)

6 (10.0%)

22 (39.3%)

25 (69.4%)

< 0.001

SAP

0 (0%)

2 (1.4%)

5 (8.3%)

11 (19.6%)

28 (77.8%)

< 0.001

Mortality

0 (0%)

2 (1.4%)

4 (6.7%)

8 (14.3%)

13 (36.1%)

< 0.001

Systemic complications

0 (0%)

7 (4.8%)

19 (31.7%)

28 (50%)

28 (77.8%)

< 0.001

Local complications

 APFC

2 (28.6%)

49 (33.3%)

22 (36.7%)

22 (39.3%)

15 (41.7%)

0.859

 ANC

0 (0%)

0 (0%)

4 (6.7%)

5 (8.9%)

2 (5.6%)

0.002

 WON

0 (0%)

2 (1.4%)

5 (8.3%)

4 (7.1%)

5 (13.9%)

0.017

 Pancreatic pseudocyst

0 (0%)

2 (1.4%)

3 (5.0%)

9 (16.1%)

5 (13.9%)

0.01

Prognostic scores

 APACHE-II score ≥ 8

0 (0%)

13 (8.8%)

8 (13.3%)

13 (23.2%)

19 (52.8%)

< 0.001

 Ranson’s score ≥ 3

0 (0%)

9 (6.1%)

6 (10.0%)

8 (14.3%)

13 (36.1%)

< 0.001

 BISAP score ≥ 3

0 (0%)

2 (1.4%)

1 (1.7%)

5 (8.9%)

6 (16.7%)

0.002

 SIRS score ≥ 2

1 (14.3%)

22 (15.0%)

17 (28.3%)

32 (57.1%)

24 (66.7%)

< 0.001

  1. VAT, Visceral adipose tissue; SMT, Skeletal muscle tissue; ICU, Intensive care unit; SAP, Severe acute pancreatitis; APFC, Acute peripancreatic fluid collection; ANC, Acute necrotic collection; WON, Walled-off necrosis; APACHE-II, Acute Physiology and Chronic Health Evaluation II; BISAP, Bedside Index of Severity in Acute Pancreatitis; SIRS, Systemic inflammatory response syndrome